RxDoctor Payments Data

Michael Ellis, DO

Psychiatry · Columbus, GANPI 1003981671

Payments from drug & device makers

$4,961in general payments, 2019–2025

Across 278 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$414
  • Supernus Pharmaceuticals, Inc.$378
  • Sunovion Pharmaceuticals Inc.$376
  • Axsome Therapeutics, Inc.$350
  • Corium, LLC$311
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$4,961100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,961 in reported general payments places this provider in the 85th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$23,697
Medicare patients
25
Services billed
390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl28$50,328
Lisdexamfetamine Dimesylate40$10,182
VyvanseLisdexamfetamine Dimesylate22$8,454
Paliperidone ErPaliperidone22$7,383
Ziprasidone Hcl38$2,530
Aripiprazole16$2,345
Atomoxetine Hcl20$1,355
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine18$1,125
Trazodone Hcl95$830
Guanfacine Hcl ErGuanfacine Hcl41$749
Naltrexone Hcl19$748
Propranolol Hcl27$692
Fluvoxamine Maleate27$678
Guanfacine Hcl11$368
Fluoxetine Hcl27$331

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,016$50,32828 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$133$8,45422 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Columbus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →